Search Results 11-20 of 8497 for zerona

  1. A Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy - Mayo Clinic

    This study is a double-blind, randomized, placebo-controlled (2:1 niraparib:placebo) study in patients with Stage III or IV ovarian cancer. Patients must have ...

  2. Publications - Translational Neuro-Oncology: Jann N. Sarkaria - Mayo Clinic Research

    The Mayo Clinic Brain Tumor Patient-Derived Xenograft National Resource provides a bibliography to help researchers identify other studies that have used ...

  3. Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma (ODYSSEY RCC) - Mayo Clinic

    The purpose of this study is to determine distinct patterns of change in the quality of life and symptom burden in mRCC patients receiving therapy.

  4. Funding - Regenerative Neurosurgery and Neuro-Oncology Lab - Mayo Clinic Research

    The Regenerative Neurosurgery and Neuro-Oncology Lab at Mayo Clinic receives funding from sources that include the NIH, nonprofits, and corporations.

  5. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

    Inclusion Criteria: Clinical and definitive histologic diagnosis of WM. Subjects must either have relapsed/refractory disease OR be treatment naïve and ...

  6. Overview - Translational Neuro-Oncology: Jann N. Sarkaria - Mayo Clinic Research

    The Sarkaria Translational Neuro-Oncology Laboratory at Mayo Clinic develops novel therapeutics for glioblastoma brain cancer and brain metastases.

  7. Request Samples - Translational Neuro-Oncology: Jann N. Sarkaria - Mayo Clinic Research

    Get the steps required to request PDX samples from the Mayo Clinic Brain Tumor Patient-Derived Xenograft National Resource.

  8. A Study of Lower Body Negative Pressure for Research and Development on Non-Invasive Monitoring Devices - Mayo Clinic

    About this study. The purpose of this study is to see how the body responds to different levels of lower body negative pressure, specifically how the ...

  9. Synucleinopathies - Mayo Clinic

    The goals of the study are to prospectively evaluate clinical and laboratory biomarkers of multiple system atrophy and Parkinson's disease at early clinical ...

  10. A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...